http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1104547-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9350556f3c9b9bac88b1f39d24c47189 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4dd05d35c3cc189b9abfc02e2dcd752 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0cdd3231f879a8aa9ebef862c049674 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cdaa5076f3dbf57d61e2bf43a3b58b5 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate | 1999-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2003-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1104547-B1 |
| titleOfInvention | In-vitro method for detecting and diagnosing acute coronary syndromes |
| abstract | The invention relates to an in vitro method of recognizing acute coronary syndroms, especially an acute myocardial infarction, by determining and evaluating the content of choline, choline and/or trimethyl ammonium derivatives selected from the group comprising phosphoryl choline, plasmalogens, and lysoplasmenyl choline, and/or the reaction products thereof selected from the group comprising 1-O-alk-1'-enyl-2 substituted glycerol and 1-O-alk-1'-enyl-2 substituted glycerol phosphate in body fluids or component parts of the body, said method comprising the following steps:drawing a sample of a suitable body fluid or component part of the body; determining the content of choline, choline and/or trimethyl ammonium derivatives selected from the group comprising phosphoryl choline, plasmalogens, and lysoplasmenyl choline, and/or the reaction products thereof selected from the group comprising 1-O-alk-1'-enyl-2 substituted glycerol and 1-O-alk-1'-enyl-2 substituted glycerol phosphate by a suitable method of determination (nuclear magnetic resonance methods, biochemical, enzymatic, immunological, clinical-chemical, chromatographic, mass spectrometric, electrochemical, photometric methods, or other methods); and evaluating the measured results, taking into account a limit value for recognition or exclusion of acute coronary syndroms, especially an acute myocardial infarction. |
| priorityDate | 1998-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.